Stimulants May Actually Lower Anxiety in Kids With ADHD
the Psychiatry Advisor take:
While there have been reports that the use of stimulants in the treatment of attention-deficit/hyperactivity disorder (ADHD) is associated with anxiety in some people, a meta-analysis has found the opposite is true: The drugs may actually lower the risk of anxiety.
Catherine Coughlin, PhD, Michael Bloch, MD, both of Yale University, New Haven, Conn., and colleagues reviewed 23 studies involving nearly 3,000 kids with ADHD. A fixed-effects meta-analysis was performed to examine the risk ratio of anxiety reported as a side effect in children treated with psychostimulants compared with those treated with placebo.
The risk of anxiety associated with stimulant treatment was significantly lower than that experienced with placebo, the researchers reported in the Journal of Child and Adolescent Psychopharmacology. Also, higher doses of stimulants were associated with a reduced measured risk of anxiety of stimulants when compared with placebo.
While the researchers say that the results don't mean there aren't any children who experience anxiety with stimulants, those risks are outweighed by the number of adolescents who seen an improvement in symptoms of anxiety, perhaps as a result of an improved in ADHD symptoms.
“Clinicians should consider rechallenging children with ADHD who report new-onset or worsening anxiety with psychostimulants, as these symptoms are much more likely to be coincidental rather than caused by psychostimulants,” the researchers conclude.
The risk of anxiety associated with stimulant treatment was significantly lower than that experienced with placebo.
A new review of studies involving nearly 3,000 children with attention-deficit/hyperactivity disorder (ADHD) concludes that, although anxiety has been reported as a side-effect of stimulant medication, psychostimulant treatment for ADHD significantly reduces the risk of anxiety.
Thus, patient reports of new-onset or worsening anxiety with the use of psychostimulants are not likely due to the medication and should not necessarily preclude stimulant use in ADHD, according to the authors of the study published in the Journal of Child and Adolescent Psychopharmacology.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Belief That Abortion Harms Women's Mental Health Appears Misinformed
- Models Derived From Electronic Health Records Effective in Predicting Suicide Risk
- Probiotics Effective in Reducing Rehospitalization for Patients With Mania
- Caffeine Sodium Benzoate Effective as Electroconvulsive Therapy Augmentation
- Personality Disorders Related to Adverse Outcomes in Bipolar Disorder
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Substance Abuse and Primary Psychosis: A Closer Look
- Preop Psychiatric Diagnoses Not Tied to Bariatric Surgery Outcomes in Teens
- Meds With Depression As Adverse Side Effect Commonly Used
- Predictors of Long-term Medication Adherence in Children With ADHD
- Antipsychotic Treatment Linked to Adiposity Changes in Youth
- Exposure to Maternal Hypertension May Up Risk for ASD, ADHD in Child